AAOS 2025: Operative Treatment of Flail Chest Injuries Does Not Reduce Opioid Requirements .
Operative Treatment of Flail Chest Injuries Does Not Reduce Pain or In-Hospital Opioid Requirements - Results from a Multi-Centred Randomized Controlled Trial
Two hundred seven patients with acute, unstable flail chest injuries were randomized to receive operative treatment (n=108) or nonoperative treatment (n=99). The primary outcome of interest was in-hospital opioid requirements, measured as daily morphine milligram equivalents (MME). Secondary outcomes included generalized pain, chest wall pain, chest tightness, shortness of breath, and SF-36 Health Outcome Scores. Outcomes were assessed at 2 weeks, 6 weeks, 3 months, 6 months, and 12 months post-injury. Overall, the results revealed no significant differences in opioid use between groups at any time point, nor were there differences in pain scores, respiratory symptoms, or health-related quality-of-life measures throughout the one-year follow-up. These findings suggest that operative treatment does not provide additional pain relief or reduce opioid consumption in patients with flail chest injuries.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics